Isoform | Protein Position | Transcript Position | Chromosomal Position (HG38) | Chromosomal Position (HG19) |
---|---|---|---|---|
IC | 26686 | 80281;80282;80283 | chr2:178566076;178566075;178566074 | chr2:179430803;179430802;179430801 |
N2AB | 25045 | 75358;75359;75360 | chr2:178566076;178566075;178566074 | chr2:179430803;179430802;179430801 |
N2A | 24118 | 72577;72578;72579 | chr2:178566076;178566075;178566074 | chr2:179430803;179430802;179430801 |
N2B | 17621 | 53086;53087;53088 | chr2:178566076;178566075;178566074 | chr2:179430803;179430802;179430801 |
Novex-1 | 17746 | 53461;53462;53463 | chr2:178566076;178566075;178566074 | chr2:179430803;179430802;179430801 |
Novex-2 | 17813 | 53662;53663;53664 | chr2:178566076;178566075;178566074 | chr2:179430803;179430802;179430801 |
Novex-3 | None | None | chr2:None | chr2:None |
SNV | RS | DUET |
PolyPhen-2 |
Condel |
Rhapsody |
REVEL |
MVP |
Source |
MAF |
Disease |
Zygosity |
Site annotation |
mCSM PPI |
Predicted PPI site |
Comments |
AFR |
AMR |
AMS |
ASJ |
EAS |
EUR |
FIN |
MDE |
NFE |
SAS |
OTH |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/L | rs867306848 | -0.669 | 0.999 | N | 0.826 | 0.424 | 0.657421573829 | gnomAD-2.1.1 | 4.02E-06 | None | None | None | None | I | None | 6.46E-05 | 0 | None | 0 | 0 | None | 0 | None | 0 | 0 | 0 |
P/L | rs867306848 | -0.669 | 0.999 | N | 0.826 | 0.424 | 0.657421573829 | gnomAD-3.1.2 | 6.58E-06 | None | None | None | None | I | None | 2.41E-05 | 0 | 0 | 0 | 0 | None | 0 | 0 | 0 | 0 | 0 |
P/L | rs867306848 | -0.669 | 0.999 | N | 0.826 | 0.424 | 0.657421573829 | gnomAD-4.0.0 | 6.57549E-06 | None | None | None | None | I | None | 2.41464E-05 | 0 | None | 0 | 0 | None | 0 | 0 | 0 | 0 | 0 |
SAV |
AlphaMissense (IC) |
AlphaMissense Class (IC) |
AlphaMissense (N2AB) |
AlphaMissense Class (N2AB) |
mCSM |
mCSM class |
PolyPhen-2 |
PolyPhen-2 Class |
Rhapsody |
Rhapsody Class |
Condel |
Condel Score |
Site annotation |
mCSM PPI |
Predicted PPI site |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/A | 0.0791 | likely_benign | 0.091 | benign | -1.714 | Destabilizing | 0.227 | N | 0.406 | neutral | N | 0.447269277 | None | None | I |
P/C | 0.4543 | ambiguous | 0.5081 | ambiguous | -1.077 | Destabilizing | 1.0 | D | 0.861 | deleterious | None | None | None | None | I |
P/D | 0.8233 | likely_pathogenic | 0.8271 | pathogenic | -1.906 | Destabilizing | 0.98 | D | 0.829 | deleterious | None | None | None | None | I |
P/E | 0.4799 | ambiguous | 0.5049 | ambiguous | -1.883 | Destabilizing | 0.988 | D | 0.82 | deleterious | None | None | None | None | I |
P/F | 0.5789 | likely_pathogenic | 0.6099 | pathogenic | -1.26 | Destabilizing | 1.0 | D | 0.873 | deleterious | None | None | None | None | I |
P/G | 0.4361 | ambiguous | 0.4744 | ambiguous | -2.053 | Highly Destabilizing | 0.973 | D | 0.791 | deleterious | None | None | None | None | I |
P/H | 0.3488 | ambiguous | 0.3548 | ambiguous | -1.643 | Destabilizing | 1.0 | D | 0.857 | deleterious | None | None | None | None | I |
P/I | 0.3724 | ambiguous | 0.4368 | ambiguous | -0.857 | Destabilizing | 1.0 | D | 0.861 | deleterious | None | None | None | None | I |
P/K | 0.3717 | ambiguous | 0.4095 | ambiguous | -1.435 | Destabilizing | 0.999 | D | 0.82 | deleterious | None | None | None | None | I |
P/L | 0.1883 | likely_benign | 0.2185 | benign | -0.857 | Destabilizing | 0.999 | D | 0.826 | deleterious | N | 0.520191502 | None | None | I |
P/M | 0.3345 | likely_benign | 0.3851 | ambiguous | -0.64 | Destabilizing | 1.0 | D | 0.865 | deleterious | None | None | None | None | I |
P/N | 0.5643 | likely_pathogenic | 0.6075 | pathogenic | -1.259 | Destabilizing | 0.999 | D | 0.871 | deleterious | None | None | None | None | I |
P/Q | 0.2232 | likely_benign | 0.2421 | benign | -1.426 | Destabilizing | 1.0 | D | 0.83 | deleterious | N | 0.506896186 | None | None | I |
P/R | 0.2826 | likely_benign | 0.3058 | benign | -0.909 | Destabilizing | 0.999 | D | 0.869 | deleterious | N | 0.503782314 | None | None | I |
P/S | 0.1757 | likely_benign | 0.191 | benign | -1.747 | Destabilizing | 0.974 | D | 0.781 | deleterious | N | 0.49166554 | None | None | I |
P/T | 0.1969 | likely_benign | 0.2294 | benign | -1.626 | Destabilizing | 0.992 | D | 0.819 | deleterious | N | 0.508163633 | None | None | I |
P/V | 0.2601 | likely_benign | 0.3105 | benign | -1.111 | Destabilizing | 0.995 | D | 0.833 | deleterious | None | None | None | None | I |
P/W | 0.8254 | likely_pathogenic | 0.8239 | pathogenic | -1.518 | Destabilizing | 1.0 | D | 0.832 | deleterious | None | None | None | None | I |
P/Y | 0.6027 | likely_pathogenic | 0.6267 | pathogenic | -1.239 | Destabilizing | 1.0 | D | 0.869 | deleterious | None | None | None | None | I |
Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.